Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of rotation from subcutaneous to transdermal fentanyl in cancer-related pain
NL-OMON54225Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fentanyl in cancer pain, sponsored by Erasmus MC. Primary endpoint: Bioequivalence in fentanyl exposure before and after rotation. Started Dec 2022; status: active, not recruiting.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on NL-OMON54225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54225.